Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
30 results
D2.314 - Late Presentation of Cutaneous Chronic Graft Versus Host Disease – A Case Report
D2.309 - Descriptive Study of Chronic Urticaria Under Treatment with Omalizumab: Our Experience
D2.310 - Dysregulation of barrier function and distribution of nerve cells in a mouse model of atopic dermatitis
D2.311 - Real World Web Survey on the Burden of Urticaria
D2.312 - Impact of metabolic disorders on immune dysregulation in psoriasis and atopic dermatitis
D2.313 - Importance of non-itchy erythema marginatum as a prodromal symptom of hereditary angioedema attacks
D2.315 - Clinical features and Progress of Diagnosis and Therapy of Hereditary Angioedema in China: A Systemic Review of Published Cases
D2.316 - The role of Tumor necrosis factor ligand superfamily member 15 in Atopic dermatitis
D2.317 - The role of sirtuin 2 (SIRT2) in atopic dermatitis
D2.318 - Triggers and prodromal indicators of angioedema attacks in hereditary angioedema patients
D2.319 - Advancing Diagnosis and Management of Hereditary Angioedema in Brazil: Insights from the first 704 patients of a Multicenter Registry
D2.322 - Quality of life of families with children suffering from chronic urticaria
D2.323 - Higher neonatal urinary phthalate are associated with the development of infantile atopic dermatitis
D2.324 - Psychological Burden Associated with Injectable HAE On-Demand Treatments: A Patient and Caregiver Interview Study
- D3.114 - Does severe asthma exist in preschool children?
- D3.115 - Outcome and complications of COVID-19 among children with asthma in South Korea: a national incident cohort study
- D3.116 - Mepolizumab as game changer in a case of severe occupational asthma with rhinitis and contact dermatitis
- D3.117 - Targeting Mast Cells with Briquilimab, an Anti-Human c-Kit (CD117) Antibody, Mitigates COPD-Like Features in an Allergen and Cigarette Smoke-Exacerbated Asthma Model Using Humanized h/mCD117 Mice
- D3.118 - Antibiotic Cocktail-Induced Gut Microbiota Dysbiosis Modulates Gut and Airway Immunity, Attenuating Allergic Airway Inflammation
- D3.119 - Selection of Biologics for Severe Pediatric Asthma with Allergic Eosinophilic Phenotype
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download